JOGO Health and SohoMD Partner to Deliver Integrated Virtual Migraine Care Nationwide
NEW YORK – October 13, 2025 – JOGO Health, a digital therapeutics company pioneering AI-driven EMG biofeedback for neurology, today announced a strategic partnership with SohoMD, a leading nationwide virtual mental health provider serving over 70,000 patients across the United States.
Through this collaboration, JOGO Health will leverage SohoMD’s extensive payer contracts and nationwide virtual provider network to expand access to its FDA-cleared digital neurology solution for migraine—a condition that affects more than 40 million Americans and over 1 billion people worldwide.
As part of the partnership, JOGO will also integrate SohoMD’s mental health providers into its migraine care programs to offer comprehensive, whole-person treatment. Migraine is frequently comorbid with depression, anxiety, and sleep disorders, and this collaboration ensures patients receive both neurological and psychological support in a unified care pathway.
The timing of this partnership is particularly significant as an upcoming Local Coverage Decision (LCD) from Medicare requires patients to undergo biofeedback and behavioral interventions before being prescribed Botox for migraine. This change positions JOGO and SohoMD at the forefront of evidence-based, reimbursable digital migraine management—helping providers and payers meet new coverage criteria while improving patient outcomes.
Mutual benefits of the partnership include:
- JOGO Health gains access to SohoMD’s national payer network and virtual provider infrastructure to scale its migraine program nationwide.
- SohoMD enhances its service portfolio by offering JOGO’s evidence-based digital migraine intervention to its patients—many of whom experience migraine symptoms alongside mental health challenges.
“This partnership bridges the gap between mental and neurological health,” said Siva Nadarajah, President and Co-Founder of JOGO Health. “By combining JOGO’s digital neurology technology with SohoMD’s experienced mental health providers, we can treat migraine more holistically—addressing both physiological and psychological triggers while aligning with emerging payer requirements.”
“Migraine and mental health disorders often go hand in hand,” said Dr. Jacques Jospitre Jr., Co-Founder and CEO of SohoMD. “Partnering with JOGO allows us to provide an integrated, non-invasive solution for our patients, improving both their mental well-being and migraine outcomes.”
Together, JOGO Health and SohoMD are redefining integrated digital care, merging neuroscience, behavioral health, and telemedicine to make high-quality migraine care more accessible, compliant, and effective nationwide.
About JOGO Health
JOGO Health is a digital neurology company offering FDA-cleared EMG biofeedback-based therapeutics for neuromuscular and neurological disorders such as migraine, stroke, and pelvic floor dysfunction. With over 25,000 patients treated and partnerships with leading institutions including Mayo Clinic and Mount Sinai, JOGO delivers evidence-based, AI-driven neurorehabilitation and migraine management solutions through telemedicine and hybrid clinical models. Learn more at www.jogohealth.com.
About SohoMD
SohoMD is a nationwide virtual mental health practice providing holistic, personalized care to over 70,000 patients. The company combines expert clinicians, evidence-based psychiatry, and integrated therapy programs to improve access to high-quality mental healthcare across the United States. Learn more at www.sohomd.com.
Media Contact
Company Name: JOGO Health
Contact Person: Eden Joy Sumido
Email: Send Email
Phone: 231-564-6389
Country: United States
Website: www.jogohealth.com
